Inhibition of allergen-induced IgE and IgG1 production by soluble IL-4 receptor

• Published in: International archives of allergy and immunology Vol. 106; no. 1; p. 46
• Main Authors: Renz, H, Enssle, K, Lauffer, L, Kurrle, R, Gelfand, E W
• Format: Journal Article
• Language: English
• Published: Switzerland 01.01.1995
• Subjects: Animals; Antibodies; Base Sequence; Cells, Cultured; DNA, Complementary; Drug Hypersensitivity - immunology; Female; Immunoglobulin E - biosynthesis; Immunoglobulin G - biosynthesis; Lymph Nodes - immunology; Mice; Molecular Sequence Data; Ovalbumin - pharmacology; Receptors, Interleukin - genetics; Receptors, Interleukin - immunology; Receptors, Interleukin - metabolism; Receptors, Interleukin-4; Spleen - immunology
• ISSN: 1018-2438
• DOI: 10.1159/000236889

In this study, the effect of soluble IL-4 receptors (sIL-4R) on murine allergen-induced IgE and IgG1 production was examined. Lymphocytes from mice sensitized to the allergens ragweed (RW) or ovalbumin (OVA) in vivo were restimulated in vitro with the sensitizing allergen in the presence of either a soluble murine sIL-4R, a dimeric sIL-4R Ig fusion protein (sIL-4R/Fc), or anti-IL-4 antibody in 14-day cultures. Both monomeric and dimeric sIL-4R inhibited polyclonal IgE (approximately 70%) and IgG1 (approximately 35%) production in a dose-dependent fashion, similar to that observed in the presence of the anti-IL-4 antibody. Allergen-specific IgE and IgG1 were inhibited to a greater degree. Addition of sIL-4R was most effective when present in the culture during the first 3 days and added not later than day 6. In kinetic experiments, we distinguished ongoing IgE production from precommitted B cells versus newly induced IgE synthesis and found that newly induced IgE production was the major target of the sIL-4Rs. These data demonstrate the efficacy of sIL-4R in inhibiting the early stages of the IgE B-cell maturation pathway and indicate the potential of sIL-4R for the inhibition of IgE production in vivo.